UK markets close in 4 hours 47 minutes

  • FTSE 100

    6,899.72
    +4.43 (+0.06%)
     

  • FTSE 250

    22,207.15
    +121.42 (+0.55%)
     

  • AIM

    1,258.36
    +12.73 (+1.02%)
     

  • GBP/EUR

    1.1548
    -0.0023 (-0.20%)
     

  • GBP/USD

    1.3919
    -0.0013 (-0.09%)
     

  • BTC-GBP

    39,017.39
    -1,111.46 (-2.77%)
     

  • CMC Crypto 200

    1,259.44
    -3.52 (-0.28%)
     

  • S&P 500

    4,173.42
    +38.48 (+0.93%)
     

  • DOW

    34,137.31
    +316.01 (+0.93%)
     

  • CRUDE OIL

    61.05
    -0.30 (-0.49%)
     

  • GOLD FUTURES

    1,788.20
    -4.90 (-0.27%)
     

  • NIKKEI 225

    29,188.17
    +679.62 (+2.38%)
     

  • HANG SENG

    28,755.34
    +133.42 (+0.47%)
     

  • DAX

    15,270.29
    +74.32 (+0.49%)
     

  • CAC 40

    6,253.00
    +42.45 (+0.68%)
     
Analysis :

What the European Super League's collapse means for JP Morgan

The European Super League is dead on arrival but the impact of the aborted project will still leave a mark on those involved

Boohoo's new warehouse to boost sales capacity to more than $5.5 billion

  • Oops!
    Something went wrong.
    Please try again later.
·2-min read
FILE PHOTO: A smartphone with the Boohoo logo displayed is seen on a keyboard in this illustration
  • Oops!
    Something went wrong.
    Please try again later.

(Reuters) - British online fashion retailer Boohoo has secured a new warehouse in central England that will boost its sales capacity to more than 4 billion pounds ($5.5 billion), it said on Friday.

Boohoo has agreed a long-term lease for the site in Daventry which is scheduled to become operational in the second quarter of its 2021-22 year.

The warehouse will support the group’s rapid expansion and adds to existing facilities in Burnley and Sheffield in northern England and Wellingborough in central England.

"In aggregate, these sites will give the group net sales capacity in excess of 4 billion pounds," Boohoo said.

Analysts estimate total revenue was about 1.7 billion pounds in 2020-21.

The new warehouse is scalable, with Boohoo expecting to invest more than 50 million pounds in the coming years.

It said the deal is expected to secure up to 500 jobs and in the future create up to a further 1,000 jobs as capacity increases at the site.

In February the group purchased the Debenhams brand out of administration for 55 million pounds and the Dorothy Perkins, Wallis and Burton brands from the administrators of Arcadia for 25.2 million pounds.

Shares in Boohoo have risen 33% over the past year, giving the group a market capitalisation of 4.4 billion pounds.

Last month Boohoo revealed a major consolidation in its supplier base as it published a full list of UK manufacturers to meet a pledge on transparency.

The list was released exactly six months after Boohoo accepted all the recommendations of an independent review led by senior lawyer Allison Levitt which found major failings in its supply chain in England in the wake of newspaper allegations about working conditions and low pay in factories in the Leicester area.

($1 = 0.7315 pounds)

(Reporting by James Davey in London and Chris Thomas in Bengaluru; editing by Amy Caren Daniel and Toby Chopra)

Latest stories

  • Swiss president heads for damage-control EU summit

    Swiss President Guy Parmelin heads to Brussels on Friday for a summit with European Commission President Ursula von der Leyen over a stalled treaty that threatens to put ties between Switzerland and its biggest trading partner into a deep freeze. That could leave Parmelin, a member of the eurosceptic Swiss People's Party, the biggest in parliament, in damage-control mode when he meets von der Leyen, who has urged Bern finally to embrace the draft accord negotiated in 2018. The Swiss cabinet has said it wants clarifications on some open points before endorsing the pact, and officials in Brussels want concrete suggestions from Parmelin, one source familiar with the talks said.

  • Southwest expects lower cash burn as vaccines drive leisure travel rebound

    U.S. airlines are preparing for a rebound in summer bookings after nearly a year in the doldrums due to the COVID-19 pandemic and accompanying travel restrictions. The company said it was adding flights and expects second-quarter capacity to rise about 90% from a year earlier, but about 15% below 2019 levels, when air travel was not hit by the COVID-19 crisis. Second-quarter average core cash burn is expected to be between $2 million and $4 million per day, Southwest said, compared with about $13 million per day in the previous three months.

  • Debit Card Acquisition in Top-10 Russian Banks 2021: Market Analysis and Trends, Rating, 100+ Best Practices - ResearchAndMarkets.com

    The "Review of Debit Card Acquisition in Top-10 Russian Banks 2021 - Market Analysis and Trends, Rating, 100+ Best Practices" report has been added to ResearchAndMarkets.com's offering.

  • Global Catering Services Market to Reach $609 Billion by 2027 - ResearchAndMarkets.com

    The "Catering Services - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

  • Etihad Airways to stop operating Boeing 777-300ER jets this year

    Abu Dhabi's Etihad Airways will no longer operate Boeing 777-300ER jets after this year, its chief executive said on Wednesday, as it accelerates planes to become a smaller airline. State-owned Etihad is targeting to return profit in 2023 as part of a five-year restructuring plan that it has accelerated during the pandemic that has crippled the air travel industry. "You will see of us a very focused, a very disciplined operating model which is heavily built around the fleet of the (Boeing) 787 Dreamliner and (Airbus) A350-1000," CEO Tony Douglas told the online World Aviation Festival.

  • Italian Hospital Worker Allegedly Skipped Work On Full Pay For 15 Years

    The man reportedly raked in around $645,000 during his unauthorized leave.

  • Global Oncolytic Virus Therapies Market Report 2021-2030: Focus on Commercialized Therapies, Pipeline Therapies, Type of Virus, Application, and Competitive Landscape

    Dublin, April 22, 2021 (GLOBE NEWSWIRE) -- The "Global Oncolytic Virus Therapies Market: Focus on Commercialized Therapies, Pipeline Therapies, Type of Virus, Application, Region (15 Countries), and Competitive Landscape - Analysis and Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering. Global Oncolytic Virus Therapies Market to Reach $962.0 Million by 2030 Oncolytic virus therapies to be one of the most rapidly evolving technologies, and the global market is predicted to grow at a CAGR of 26.28% over the forecast period 2020-2030. Market OverviewOncolytic virus therapies are overlapping biomedical research fields with similar therapeutic goals, which target DNA or RNA inside or outside the body. These therapies aim at modifying genetic material for the treatment of a disease. Oncolytic virotherapy is a form of gene therapy that used nature's material (virus) to find and destroy malignant cells. Oncolytic virus therapy is "a novel approach to treat, cure, or ultimately prevent disease by changing the expression of a person's genes". Oncolytic virotherapy is a form of gene therapy that used nature's material (virus) to find and destroy malignant cells.Factors fueling the growth of the market include prevalence of cancer, rising number of clinical trials, boosting research funding, and adoption of inorganic growth. Despite rapid advanced industry growth, there are several key issues that need to be addressed to facilitate future growth such as the relatively high total costs of therapies and lacking therapy-specific assay. Further, some of the opportunities such as clinical pipeline of therapies provide growth to the market.Within the research report, the market has been segmented on the basis of commercialized therapies, pipeline therapies, type of virus, application, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.Competitive LandscapeThe exponential rise in the cases of cancer on the global level has created a buzz among companies to invest in the therapeutics of advanced technologies. Due to a large number of pipeline therapies and intense market penetration, oncolytic virus therapies have been pioneers in the therapeutic field and have significant competitors in this market.Based on region, North America held the largest share in 2020, owing to improved healthcare infrastructure, rise in per capita income, and improvised reimbursement policies in the region. Apart from this, Europe and the Asia-Pacific are anticipated to grow at the fastest CAGR during the forecast period. Key Questions Answered in this Report: What are the major market drivers, challenges, and opportunities in the global oncolytic virus therapies market?What are the key development strategies being implemented by the major players in order to sustain in the competitive market?What are the key regulatory implications in developed and developing regions for the global oncolytic virus therapies market?How is each segment of the market expected to grow during the forecast period 2020-2030?Who are the leading players with significant offerings to the global oncolytic virus therapies market, and what is the expected market dominance for each of these leading players?What are the adoption trends for oncolytic virus therapies in established economies and emerging economies across the world?What is the COVID-19 impact on the global oncolytic virus therapies market?Which companies are anticipated to be highly disruptive in the future, and why?What are the unmet needs that are yet to be met by the global oncolytic virus therapies with respect to the application areas?What are the dynamics of various application areas and countries, which are impacting the global oncolytic virus therapies market?What are the new market opportunities of various technologies that are influencing the growth of the global oncolytic virus therapies market?How is each segment of the market expected to grow during the forecast period 2020-2030? The following are the segment types: Commercialized TherapiesPipeline TherapiesType of VirusApplicationRegion Key Topics Covered: 1 Product Definition1.1 Inclusion and Exclusion2 Market Scope2.1 Scope of Work2.2 Key Questions Answered in the Report3 Research Methodology3.1 Global Oncolytic Virus Therapies Market: Research Methodology3.2 Primary Data Sources3.3 Secondary Data Sources3.4 Market Estimation Model3.5 Criteria for Company Profiling4 Market Overview4.1 Market Definition4.2 Importance of Oncolytic Virus Therapies in Cancer Treatment4.3 Market Size and Growth Potential, $Million, 2019-20304.4 COVID-19 Impact on the Global Oncolytic Virus Therapies Market5 Industry Insights5.1 Overview5.2 Regulatory Scenario5.3 Legal Requirements and Framework in the U.S5.3.1 Clinical Trial Authorization5.3.2 U.S. FDA Guidelines for BLA Submission5.4 Legal Requirements and Framework in Europe5.4.1 EMA Biologics License Application Process5.4.2 Centralized Procedure5.4.3 Decentralized Procedure5.4.4 Mutual-Recognition Procedure5.5 Legal Requirements and Framework in Asia-Pacific5.5.1 China5.5.2 Japan5.6 Expedited Regulatory Designations Around the World5.7 Reimbursement Scenario5.8 Patent Analysis5.8.1 Patent Filing Trend6 Market Dynamics6.1 Overview6.2 Impact Analysis6.3 Market Drivers6.3.1 Increasing Incidence of Cancer6.3.2 Rising Number of Clinical Trials6.3.3 Increasing Research Funding from National Cancer Institute6.3.4 Increasing Adoption of Inorganic Growth Strategies in the Market6.4 Market Restrains6.4.1 High Cost of Therapy6.4.2 Lack of Therapy-Specific Assays6.5 Market Opportunities6.5.1 Opportunities in the Emerging Economies6.5.2 Drug Approvals and Strong Pipeline of Oncolytic Virus Therapies7 Competitive Landscape7.1 Synergistic Activities7.2 Business Expansion Activities and Others7.3 Product Launches and Product Updates7.4 Mergers and Acquisitions7.5 Market Share Analysis7.6 Growth Share Analysis7.6.1 Growth Share Analysis (by Commercialized Therapy)8 Oncolytic Virus Therapies: Epidemiology Analysis9 Global Oncolytic Virus Therapies Market (by Commercialized Therapies), $Million, 2019-20309.1 Overview9.2 Imlygic9.3 Oncorine9.4 RIGVIR10 Global Oncolytic Virus Therapies Market (by Pipeline Therapies), $Million, 2019-203010.1 Overview10.2 Phase I10.3 Phase II10.4 Phase III10.5 Phase IV11 Global Oncolytic Virus Therapies Market (by Type of Virus), $Million, 2019-203011.1 Overview11.2 Genetically Engineered Oncolytic Virus11.2.1 Herpes Simplex Virus (HSV)11.2.2 Adenovirus11.2.3 Vaccinia Virus11.3 Oncolytic Wild-Type Virus11.3.1 Reovirus (Respiratory Enteric Orphan Virus)11.3.2 Newcastle Disease Virus (NDV)11.3.3 Vesicular Stomatitis Virus (VSV)12 Global Oncolytic Virus Therapies Market (by Application), $Million, 2019-203012.1 Overview12.2 Solid Tumor12.2.1 Breast Cancer12.2.2 Prostate Cancer12.2.3 Lung Cancer12.2.4 Glioblastoma12.2.5 Melanoma12.2.6 Other Applications12.3 Hematological Malignancies12.3.1 Lymphoma12.3.2 Leukemia12.3.3 Myeloma13 Global Oncolytic Virus Therapies Market (by Region), $Million, 2019-203013.1 Overview14 Company Profiles Amgen Inc.DAIICHI SANKYO COMPANY, LIMITEDDNAtrixGeneluxOncolytics Biotech, Inc.PsiOxus TherapeuticsRIGVIR Ltd.Shanghai Sunway Biotech Co., Ltd.,SillaJen, Inc.Sorrento Therapeutics, Inc.Takara Bio Inc.Transgene saVCNBiosciencesViroCureViralytics Ltd. (Merck & Co., Inc.) For more information about this report visit https://www.researchandmarkets.com/r/i5dgst CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

  • Cathie Wood's ARK Invest piles into UiPath, trims Tesla

    UiPath's shares surged 23.2% in their New York Stock Exchange debut, underscoring investors' appetite for high-growth tech stocks. ARK Invest's data showed the firm's exchange traded funds bought a total of about 2.7 million shares, about a third of the day's traded volume. The ARK Next Generation Internet ETF and the ARK Innovation ETF also bought a total of 247,717 shares of crypto exchange Coinbase Global Inc, which went public last week.

  • These Myths Could Wreck Your Retirement -- but They Don't Have To

    Here's how to work around some common retirement misconceptions -- and enjoy your senior years to the fullest.

  • Global A2P SMS Market Size by Application, by End-User, by Geographic Scope And Forecast 2021-2027 - ResearchAndMarkets.com

    The "Global A2P SMS Market Size by Application, by End-User, by Geographic Scope And Forecast" report has been added to ResearchAndMarkets.com's offering.

  • Man jailed for ‘abhorrent’ attack on transgender woman

    Neil Cleal also pleaded guilty to assaulting an emergency worker.

  • Talking Horses: Havlin appeals against 21-day ban for Lingfield ride

    Talking Horses: Havlin appeals against 21-day ban for Lingfield rideJockey suspended after ‘failing to take all reasonable and permissible measures to obtain the best possible placing’ Robert Havlin will lodge an appeal against a 21-day ban handed out at Lingfield on Wednesday. Photograph: Getty Images

  • Global Self-Propelled Railway, Tramway Coaches, Vans and Trucks: 2021 Market Analysis, Forecast, Size, Trends and Insights - ResearchAndMarkets.com

    The "World - Self-Propelled Railway or Tramway Coaches, Vans and Trucks - Market Analysis, Forecast, Size, Trends and Insights. Update: COVID-19 Impact" report has been added to ResearchAndMarkets.com's offering.

  • AT&T Reports First-Quarter Results

    AT&T Inc. (NYSE:T) reported first-quarter results that showed continuing customer growth in wireless, fiber and HBO Max and strong cash flows.

  • Arsenal director Josh Kroenke to face fans forum questions over Super League debacle

    Josh Kroenke is set to face questions from disgruntled fans over Arsenal’s involvement in the failed European Super League later on Thursday. The American - vice-chairman of Kroenke Sports & Entertainment (KSE) and KSE UK - is the son of Arsenal’s billionaire owner Stan Kroenke and has served as a director at the club since 2013. Arsenal’s fans forum scheduled for this week was initially postponed in the wake of the Super League fiasco, but is set to take place at 4:30pm BST on Thursday afternoon.

  • Should You Buy Sundial Growers on the Dip?

    It has been a volatile year for cannabis producer Sundial Growers (NASDAQ: SNDL). With tons of cash on its books and Sundial looking for a deal, this is a stock that still has plenty of potential to rise in value. A drop in price doesn't mean investors should ignore the risks involved with Sundial.

  • Susanna Reid’s long-sleeved LK Bennett dress is perfect for grown-up glam - and it's half price

    We love the deep wine colour.

  • Global Healthcare RCM Outsourcing Market Report 2021: Market Reached a Value of $14.6 Billion in 2020 - Forecast to 2026

    Dublin, April 22, 2021 (GLOBE NEWSWIRE) -- The "Healthcare RCM Outsourcing Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global healthcare RCM outsourcing market reached a value of US$ 14.6 Billion in 2020. Looking forward, the global healthcare RCM outsourcing market to exhibit strong growth during the next five years. Revenue Cycle Management (RCM) is a financial process which is used for managing payment, claim processing and revenue generation. It is utilised by medical billing companies or healthcare facilities for the purpose of addressing issues and following up the claims process. There are numerous benefits which are offered by RCM outsourcing such as doctors have a better control and understanding of their revenue cycles. It also helps in maintaining billing operations and reducing the operating costs of office infrastructure, software and equipment. Governments across various nations have been introducing stringent regulations over the past few years regarding healthcare, due to which there has been a significant rise in the operating costs of healthcare facilities and medical billing companies. This has created opportunities for outsourcing companies to assist them in revenue cycle management which acts as a major factor driving the growth of the global healthcare RCM outsourcing market. In addition to this, healthcare facilities have been facing several issues like rising financial challenges which has resulted in the need for augmented speed of billing. This, in turn, has highly contributed towards a propelling growth in the demand for RCM outsourcing agencies. Moreover, other factors which are bolstering the growth of the market include increasing industrialisation and urbanisation rates as well as a rapid rise in the prevalence of diseases across the globe. Market Summary:Based on type, the market has been segmented as pre-intervention, intervention and post-intervention.The market has been further segregated on the basis of services which include back-end services, middle services and front-end services. Among these, back-end services hold the majority of the market share.On the basis of end-user, hospitals represent the largest segment.Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. Currently, North America is the leading market owing to the rising adoption of advanced technologies which include electric health record (EHR) systems and hospital information systems.The competitive landscape of the market has also been examined with some of the key players being Conifer Health Solutions, Emdeon Business Services, MedAssets, McKesson, Parallon Business Solutions and The SSI Group.Key Questions Answered in This Report: How has the global healthcare RCM outsourcing market performed so far and how will it perform in the coming years?What are the key regions in the global healthcare RCM outsourcing market?What has been the impact of COVID-19 on the global healthcare RCM outsourcing market?Which are the popular product types in the global healthcare RCM outsourcing market?What are the key end-user segments in the global healthcare RCM outsourcing market?What are the major services in the global healthcare RCM outsourcing market?What are the various stages in the value chain of the global healthcare RCM outsourcing industry?What are the key driving factors and challenges in the global healthcare RCM outsourcing industry?What is the structure of the global healthcare RCM outsourcing industry and who are the key players?What is the degree of competition in the global healthcare RCM outsourcing industry? Key Topics Covered: 1 Preface2 Scope and Methodology3 Executive Summary4 Introduction4.1 Overview4.2 Key Industry Trends5 Global Healthcare RCM Outsourcing Market5.1 Market Overview5.2 Market Performance5.3 Impact of COVID-195.4 Price Analysis5.5 Market Breakup by Type5.6 Market Breakup by Services5.7 Market Breakup by End-User5.8 Market Breakup by Region5.9 Market Forecast5.10 SWOT Analysis5.11 Value Chain Analysis5.11.1 Overview5.11.2 Research and Development5.11.3 Inputs5.11.4 Products and Services5.11.5 Marketing and Distribution5.11.6 End Users5.11.7 Post Sales Services5.12 Porters Five Forces Analysis6 Market Breakup by Type6.1 Pre-intervention6.2 Intervention6.3 Post-intervention7 Market Breakup by Services7.1 Back-end 7.2 Middle 7.3 Front-end 8 Market Breakup by End-User8.1 Hospitals8.2 Others9 Market Breakup by Region10 Competitive Landscape10.1 Market Structure10.2 Key Players10.3 Profiles of Key Players10.3.1 Conifer Health Solutions10.3.2 Emdeon Business Services10.3.3 MedAssets10.3.4 McKesson10.3.5 Parallon Business Solutions10.3.6 The SSI GroupFor more information about this report visit https://www.researchandmarkets.com/r/50tqb8 CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

  • Opendoor and iBuying: What Investors Need to Know

    There's a new trend among real estate technology companies called iBuying, which refers to the practice of buying homes directly from sellers and then selling them directly to buyers, hopefully for a profit. Big real estate players like Zillow (NASDAQ: Z)(NASDAQ: ZG) and Redfin (NASDAQ: RDFN) are rapidly growing their iBuying operations. In this Fool Live video clip, recorded on April 12, Fool.com contributor Matt Frankel, CFP, and Industry Focus host Jason Moser discuss Opendoor and the potential of iBuying.

  • AT&T beats revenue, wireless subscribers estimates

    The company has been investing heavily in its 5G wireless network and bundling free streaming service for HBO Max with certain phone plans to attract customers. AT&T's WarnerMedia added 2.7 million HBO Max and HBO subscribers in the quarter as viewers flocked to Netflix Inc's rival that began making its entire box office slate available on streaming service the same day the movies hit theaters. HBO and HBO Max had 44.2 million U.S. subscribers at the end of the quarter, AT&T said.